Page:United States Statutes at Large Volume 98 Part 2.djvu/913

This page needs to be proofread.
PUBLIC LAW 98-000—MMMM. DD, 1984

PUBLIC LAW 98-473—OCT. 12, 1984

98 STAT. 2073

determine the period of such registrations. In no event, however, shall such registrations be issued for less than one year nor for more than three years.". SEC. 511. Section 303(f) (21 U.S.C. 823(f)) is amended to read as follows: "(f) The Attorney General shall register practitioners (including pharmacies, as distinguished from pharmacists) to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, if the applicant is authorized to dispense, or conduct research with respect to, controlled substances under the laws of the State in which he practices. The Attorney General may deny an application for such registration if he determines that the issuance of such registration would be inconsistent with the public interest. In determining the public interest, the following factors shall be considered: "(1) The recommendation of the appropriate State licensing board or professional disciplinary authority. "(2) The applicant's experience in dispensing, or conducting research with respect to controlled substances. "(3) The applicant's conviction record under Federal or State laws relating to the manufacture, distribution, or dispensing of controlled substances. "(4) Compliance with applicable State, Federal, or local laws relating to controlled substances. "(5) Such other conduct which may threaten the public health and safety. Separate registration under this part for practitioners engaging in research with controlled substances in schedule 11, III, IV, or V, who are already registered under this part in another capacity, shall not be required. Registration applications by practitioners wishing to Research and conduct research with controlled substances in schedule I shall be development, referred to the Secretary, who shall determine the qualifications and competency of each practitioner requesting registration, as well as the merits of the research protocol. The Secretary, in determining the merits of each research protocol, shall consult with the Attorney General as to effective procedures to adequately safeguard against diversion of such controlled substances from legitimate medical or scientific use. Registration for the purpose of bona fide research with controlled substances in schedule I by a practitioner deemed qualified by the Secretary may be denied by the Attorney General only on a ground specified in section 304(a). Article 7 of the Conven- Infra. tion on Psychotropic Substances shall not be construed to prohibit, 32 UST 543. or impose additional restrictions upon, research involving drugs or other substances scheduled under the convention which is conducted in conformity with this subsection and other applicable provisions of this title.". SEC. 512. Section 304(a) (21 U.S.C. 824(a)) is amended— (1) by inserting before the period in paragraph (3) the following: "or has had the suspension, revocation, or denial of his registration recommended by competent State authority"; and (2) by striking out "or" at the end of paragraph (2), by striking out the period at the end of paragraph (3) and inserting in lieu thereof "; or", and by adding after paragraph (3) the following: "(4) has committed such acts as would render his registration under section 303 inconsistent with the public interest as deter- 21 USC 828. mined under such section.". SEC. 513. Section 304 (21 U.S.C. 824) is amended by adding at the end the following: